Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Julie Tibbets|Elizabeth Mulkey
ID:
1b826ccc-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
1 articles
Charting a Conditional Approval Pathway for Rare Disease Drugs – A Top Priority for a Revamped FDA?
Life Sciences Perspectives ·
April 23, 2025
cite